modality

MR-Linac (MR-Guided Radiotherapy)

Hybrid radiotherapy device combining a linear accelerator with an integrated MRI scanner. Enables real-time soft-tissue imaging during treatment — so the therapist can see the tumor + critical organs moving in real time rather than inferring position from bony anatomy via CBCT. Supports adaptive radiotherapy — the treatment plan is modified daily based on that day's anatomy, not the simulation scan from weeks earlier.

The first clinical MR-Linac was Elekta Unity (FDA cleared 2018). ViewRay MRIdian followed a different architectural path (lower field strength) and preceded Unity to market with an earlier 0.35 T Cobalt-60 version.

Clinical significance

MR-Linac addresses specific limitations of conventional image-guided RT:

Clinical outcomes data still accumulating. Pancreatic SBRT and stereotactic prostate boost have the best-characterized benefit so far.

Two competing architectures

Key specs

Dosimetric physics

In a 1.5 T field, secondary electrons produced by the beam curve in the magnetic field (Lorentz force) — the "electron return effect" produces dose perturbations at tissue/air or tissue/bone interfaces. Treatment planning must account for this; beam data + TPS commissioning are not interchangeable with conventional linac commissioning.

Install reality

MR-Linac install is extreme — combines:

Multi-month site prep; install cost in the eight figures. Site count globally in the hundreds.

Systems

Regulatory

Full RT facility license + MRI safety program + state radiation license + QMP + RSO. Combines the full regulatory burden of both parent modalities.

Related